CDK4/6 inhibitor (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDK4/6 inhibitor (class), covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors: